| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |